Apeloa Pharmaceutical Co Ltd (000739) - Total Assets
Based on the latest financial reports, Apeloa Pharmaceutical Co Ltd (000739) holds total assets worth CN¥12.25 Billion CNY (≈ $1.79 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Apeloa Pharmaceutical Co Ltd - Total Assets Trend (1994–2025)
This chart illustrates how Apeloa Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see 000739 stock market capitalisation for the company's overall valuation and market capitalisation.
Apeloa Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Apeloa Pharmaceutical Co Ltd's total assets of CN¥12.25 Billion consist of 64.0% current assets and 36.0% non-current assets. Review how much debt does Apeloa Pharmaceutical Co Ltd carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 30.7% |
| Accounts Receivable | CN¥2.36 Billion | 19.2% |
| Inventory | CN¥1.60 Billion | 13.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥348.95 Million | 2.8% |
| Goodwill | CN¥20.31 Million | 0.2% |
Asset Composition Trend (1994–2025)
This chart illustrates how Apeloa Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 000739 share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Apeloa Pharmaceutical Co Ltd's current assets represent 64.0% of total assets in 2025, an increase from 48.5% in 1994.
- Cash Position: Cash and equivalents constituted 30.7% of total assets in 2025, up from 4.2% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 1994.
- Asset Diversification: The largest asset category is accounts receivable at 19.2% of total assets.
Apeloa Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Apeloa Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Apeloa Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.55 | 1.51 | 1.62 |
| Quick Ratio | 1.28 | 1.20 | 1.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.81 Billion | CN¥2.76 Billion | CN¥2.17 Billion |
Apeloa Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Apeloa Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.96 |
| Latest Market Cap to Assets Ratio | 0.32 |
| Asset Growth Rate (YoY) | -3.2% |
| Total Assets | CN¥12.32 Billion |
| Market Capitalization | $3.98 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Apeloa Pharmaceutical Co Ltd's assets below their book value (0.32x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Apeloa Pharmaceutical Co Ltd's assets decreased by 3.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Apeloa Pharmaceutical Co Ltd (1994–2025)
The table below shows the annual total assets of Apeloa Pharmaceutical Co Ltd from 1994 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥12.32 Billion ≈ $1.80 Billion |
-3.23% |
| 2024-12-31 | CN¥12.73 Billion ≈ $1.86 Billion |
-0.30% |
| 2023-12-31 | CN¥12.77 Billion ≈ $1.87 Billion |
+6.21% |
| 2022-12-31 | CN¥12.02 Billion ≈ $1.76 Billion |
+32.91% |
| 2021-12-31 | CN¥9.04 Billion ≈ $1.32 Billion |
+20.68% |
| 2020-12-31 | CN¥7.49 Billion ≈ $1.10 Billion |
+14.91% |
| 2019-12-31 | CN¥6.52 Billion ≈ $954.46 Million |
+13.40% |
| 2018-12-31 | CN¥5.75 Billion ≈ $841.66 Million |
+1.07% |
| 2017-12-31 | CN¥5.69 Billion ≈ $832.79 Million |
+1.28% |
| 2016-12-31 | CN¥5.62 Billion ≈ $822.23 Million |
+4.15% |
| 2015-12-31 | CN¥5.39 Billion ≈ $789.45 Million |
+6.58% |
| 2014-12-31 | CN¥5.06 Billion ≈ $740.70 Million |
+8.57% |
| 2013-12-31 | CN¥4.66 Billion ≈ $682.23 Million |
+13.51% |
| 2012-12-31 | CN¥4.11 Billion ≈ $601.02 Million |
+13.25% |
| 2011-12-31 | CN¥3.63 Billion ≈ $530.70 Million |
+96.61% |
| 2010-12-31 | CN¥1.84 Billion ≈ $269.92 Million |
+5.42% |
| 2009-12-31 | CN¥1.75 Billion ≈ $256.03 Million |
+0.49% |
| 2008-12-31 | CN¥1.74 Billion ≈ $254.78 Million |
+7.87% |
| 2007-12-31 | CN¥1.61 Billion ≈ $236.20 Million |
+27.63% |
| 2006-12-31 | CN¥1.26 Billion ≈ $185.07 Million |
+10.47% |
| 2005-12-31 | CN¥1.14 Billion ≈ $167.53 Million |
+2.73% |
| 2004-12-31 | CN¥1.11 Billion ≈ $163.08 Million |
+29.13% |
| 2003-12-31 | CN¥863.07 Million ≈ $126.29 Million |
+25.21% |
| 2002-12-31 | CN¥689.28 Million ≈ $100.86 Million |
+17.35% |
| 2001-12-31 | CN¥587.38 Million ≈ $85.95 Million |
+29.95% |
| 2000-12-31 | CN¥452.01 Million ≈ $66.14 Million |
-13.13% |
| 1999-12-31 | CN¥520.33 Million ≈ $76.14 Million |
+14.74% |
| 1998-12-31 | CN¥453.48 Million ≈ $66.36 Million |
+15.47% |
| 1997-12-31 | CN¥392.71 Million ≈ $57.47 Million |
+138.92% |
| 1996-12-31 | CN¥164.37 Million ≈ $24.05 Million |
+12.36% |
| 1995-12-31 | CN¥146.29 Million ≈ $21.41 Million |
+3.38% |
| 1994-12-31 | CN¥141.51 Million ≈ $20.71 Million |
-- |
About Apeloa Pharmaceutical Co Ltd
Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&… Read more